Common and recurrent dysregulated molecular network of placental hypoxia and associated vasculogenesis and angiogenesis in fetal growth restriction

Read full text
Authors: W. W. Y. Li, Xiaoyi Bai, Oi Ka Chan, Maran Bo Wah Leung, So Ling Lau, Chi Chiu Wang, Tak Yeung Leung
Cited by: 1
References: 68

Abstract

Fetuses with fetal growth restriction (FGR) and selective FGR (sFGR) face elevated health risks both before and after birth. Although the underlying pathomechanisms remain unclear, placental dysfunction is recognized as a major contributing factor. By integrating untargeted transcriptomic data from FGR/sFGR placentae, this study identified 69 differentially expressed mRNAs (DEmRs) and eight differentially expressed miRNAs (DEmiRs). Functional enrichment analysis demonstrated significant enrichment in the angiogenesis and vasculogenesis pathways, with the hypoxia-related genes HIF1A and VEGFA serving as key nodes in the molecular network. Further validation through RNA sequencing (RNAseq), quantitative real-time PCR (RT-qPCR), and immunohistochemistry demonstrated that the expression of the transcriptional regulator HIF1A and the angiogenic factor VEGFA was upregulated in the placentae of sFGR twins and was significantly associated with clinical severity. Our results indicate that placental hypoxia, vasculogenesis, and angiogenesis via the molecular network of HIF1A and VEGFA may play an important role in the pathomechanisms of FGR and sFGR.

Fields of Study & Subjects

Pregnancy and preeclampsia studies Birth Development and Health Neonatal and fetal brain pathology

Publication details

Journal / source
Frontiers in Endocrinology
Publisher
Frontiers Media SA
Volume
17
Pages
1729898–1729898
Publication date
25 February 2026
Language
EN